BTI
INDV icon

Blue Trust Inc’s Indivior Pharmaceuticals INDV Stock Holding History

Blue Trust Inc’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.1K Sell
2,122
-598
-22% -$21.7K ﹤0.01% 1106
2026
Q1 		$82.9K Sell
2,720
-2,139
-44% -$70.6K ﹤0.01% 1112
2025
Q4 		$176K Buy
4,859
+733
+18% +$22.4K ﹤0.01% 833
2025
Q3 		$99.5K Buy
+4,126
New +$86.3K ﹤0.01% 1070

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Blue Trust Inc's INDV Position: Q2 2026 in Review

Blue Trust Inc reduced its Indivior Pharmaceuticals (INDV) stake by 22% in Q2 2026, selling an estimated $21.7K and leaving 2,122 shares worth $87.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1106.

Blue Trust Inc first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. The position peaked at $176K in Q4 2025. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Blue Trust Inc held 2,122 shares of Indivior Pharmaceuticals worth $87.1K as of Q2 2026.
  • Blue Trust Inc sold 598 Indivior Pharmaceuticals shares in Q2 2026, an estimated $21.7K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1106 holding.
  • Blue Trust Inc first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Blue Trust Inc's Indivior Pharmaceuticals position peaked at $176K in Q4 2025.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.